During the full time period, 71.6% of GLP-1 RA prescriptions had a dispense within 60 days of their prescription (e.g., were initiated within 60 days)
Thus, researchers value GLP1-T because it offers: High stability under standard storage and handling conditions Strong GLP-1 receptor agonism, ensuring consistent receptor activation in models Extended activity compared to natural GLP-1, enabling long-duration experiments Reliable solubility in common research diluents for ease of use These qualities make GLP1-S a key peptide in studies related to obesity, diabetes, and metabolic research
Rapid heartbeat or inability to tolerate oral fluids
after the first year
By choosing Wegovy, you benefit from our commitment to safe, effective, and individualized care
Because the proposed mechanisms are distinctly different for both glycemic improvements and CV risk reductions, the benefit of combining the use of these 2 classes can be speculated